Publications en collaboration avec des chercheurs de Instituto de Investigación Sanitaria del Hospital Universitario La Paz (8)

2024

  1. Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile

    Open Forum Infectious Diseases, Vol. 11, Núm. 4

2023

  1. CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

    Science advances, Vol. 9, Núm. 33, pp. eadf6692

2022

  1. Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19

    Chest, Vol. 162, Núm. 5, pp. 1006-1016

  2. The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients

    Journal of Pathology, Vol. 258, Núm. 4, pp. 426-436

2021

  1. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type i conventional dendritic cells

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5

2020

  1. Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis

    Modern Pathology, Vol. 33, Núm. 8, pp. 1458-1465

2018

  1. A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

    Nature Communications, Vol. 9, Núm. 1

  2. CD137 (4-1BB) signalosome: Complexity is a matter of TRAFs

    Frontiers in Immunology, Vol. 9, Núm. NOV